FDA approves Teva’s once-monthly schizophrenia treatment...

Science and health | Oct 9, 2026, 1:07 PM

Teva Pharmaceutical Industries, an Israeli company, has received U.S. Food and Drug Administration approval for WELTRUZA, a new long-acting injectable treatment for schizophrenia.

The once-monthly injection eliminates the need for daily medication in managing the condition.

PRO: see who's reacting and what you're missing. See the whole picture →

Permalink on AllIsrael.chat